InvestorsHub Logo
Followers 144
Posts 27620
Boards Moderated 3
Alias Born 02/07/2004

Re: Spideyboy post# 2571

Tuesday, 12/22/2020 5:31:30 AM

Tuesday, December 22, 2020 5:31:30 AM

Post# of 3895

This would lend to the idea that all cells that get exposed to opaganib before infection could be saved, so treatment with opaganib would be better to be done as soon as possible and prior to other treatments.

Given the DSMB recently unanimously recommended for the global phase 2/3 opaganib study to continue after a safety analysis of 70 patients, then we can at least assume safety isn't an issue and thus can be given to all patients as soon as possible.

Hopefully we have a great Covid treatment here. Another benefit, is that as Opaganib is working on a host-cell factor, it should keep being effective despite any mutations Covid might undergo including the new UK variant.



Very insightful and well written post, thank you Spideyboy!
Fingers crossed for official positive results to be published
by RDHL hopefully as a Xmas present to humanity!

smile
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RDHL News